Japan Tissue Engineering Overview

  • Founded
  • 1999
Founded
  • Status
  • Public
  • Employees
  • 200
Employees
  • Stock Symbol
  • 7774
Stock Symbol
  • Share Price
  • $6.79
  • (As of Friday Closing)

Japan Tissue Engineering General Information

Description

Japan Tissue Engineering Co., Ltd. is a bio-venture enterprise. It is engaged in the development, manufacture, and sale of tissue-engineered medical products and related products. It operates through the Regenerative Medicine, and Research and Development support business segments. The main business goal is to use autologous culturing techniques to develop tissue-engineered medical products and then to manufacture and sell these same tissue-engineered products to medical institutions for medical treatment. The company's tissue-engineered medical products are used in autologous transplant cases, where living cells are taken from the actual patient himself, cultured and then transplanted back to that same patient.

Contact Information

Website
www.jpte.co.jp
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Stock Exchange
TKS
Primary Office
  • 6-209-1 Miyakitadori
  • Gamagori, Aichi 443-0022
  • Japan
+81 0000-00-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Japan Tissue Engineering Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$6.79 $6.79 $5.72 - $7.97 $276M 40.6M 51K -$0.08

Japan Tissue Engineering Financials Summary

In Thousands,
USD
TTM 31-Dec-2020 FY 2020 31-Mar-2020 FY 2019 31-Mar-2019 FY 2018 31-Mar-2018
EV 190,463 163,923 313,481 635,786
Revenue 20,492 21,243 21,267 20,491
EBITDA (1,003) (2,019) 2,928
Net Income (3,131) (2,640) (3,006) 2,056
Total Assets 77,388 78,202 78,932 84,907
Total Debt 0 28 56 74
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Japan Tissue Engineering Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Japan Tissue Engineering‘s full profile, request access.

Request a free trial

Japan Tissue Engineering Executive Team (4)

Name Title Board Seat Contact Info
Ken-ichiro Hata Ph.D Chairman, Chief Executive Officer and President
Toshihiro Osuka Senior Executive Officer and Chief Director of Sales Promotion
You’re viewing 2 of 4 executive team members. Get the full list »

Japan Tissue Engineering Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Japan Tissue Engineering Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Japan Tissue Engineering‘s full profile, request access.

Request a free trial